Immediate Impact
1 by Nobel laureates 57 standout
Citing Papers
Metabolic reprogramming in cancer: Mechanisms and therapeutics
2023 Standout
Adaptive immunity to SARS-CoV-2 and COVID-19
2021 Standout
Works of C. Soh being referenced
A randomized, double-blind, placebo-controlled, phase IIIb trial (ATLAS) comparing bevacizumab (B) therapy with or without erlotinib (E) after completion of chemotherapy with B for first-line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer (NSCLC)
2009
Interpretation of the Tuberculin Skin Test in Mycobacterium bovis BCG-vaccinated Singaporean Schoolchildren
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| C. Soh | 141 | 161 | 2 | 88 | 11 | 343 | |
| Paola Del Prete | 95 | 82 | 9 | 59 | 15 | 341 | |
| Douglas K. Hanks | 51 | 68 | 13 | 103 | 16 | 383 | |
| Baruch D. Jakubovic | 44 | 62 | 32 | 34 | 15 | 321 | |
| Philip Young | 38 | 57 | 73 | 152 | 16 | 380 | |
| NH Mulder | 135 | 54 | 17 | 75 | 8 | 402 | |
| Delphine Morel | 93 | 54 | 7 | 96 | 18 | 359 | |
| Daniel L. Dennis | 54 | 151 | 30 | 118 | 12 | 351 | |
| John P. Panagiotou | 119 | 45 | 4 | 43 | 15 | 381 | |
| Caroleen Quach | 180 | 65 | 3 | 28 | 13 | 331 | |
| José Luiz Jesus de Almeida | 198 | 161 | 7 | 216 | 12 | 387 |
All Works
Loading papers...